Literature DB >> 27355402

Complement Activation in Trauma Patients Alters Platelet Function.

Gelareh Atefi1, Omozuanvbo Aisiku, Nathan Shapiro, Carl Hauser, Jurandir Dalle Lucca, Robert Flaumenhaft, George C Tsokos.   

Abstract

Trauma remains the main cause of death for both civilians and those in uniform. Trauma-associated coagulopathy is a complex process involving inflammation, coagulation, and platelet dysfunction. It is unknown whether activation of complement, which occurs invariably in trauma patients, is involved in the expression of trauma-associated coagulopathy. We designed a prospective study in which we enrolled 40 trauma patients and 30 healthy donors upon arrival to the emergency department of BIDMC. Platelets from healthy individuals were incubated with sera from trauma patients and their responsiveness to a thrombin receptor-activating peptide was measured using aggregometry. Complement deposition on platelets from trauma patients was measured by flow cytometry. Normal platelets displayed hypoactivity after incubation with trauma sera even though exposure to trauma sera resulted in increased agonist-induced calcium flux. Depletion of complement from sera further blocked activation of hypoactive platelets. Conversely, complement activation increased aggregation of platelets. Platelets from trauma patients were found to have significantly higher amounts of C3a and C4d on their surface compared with platelets from controls. Depletion of complement (C4d, C3a) reversed the ability of trauma sera to augment agonist-induced calcium flux in donor platelets. Our data indicate that complement enhances platelet aggregation. Despite its complement content, trauma sera render platelets hypoactive and complement depletion further blocks activation of hypoactive platelets. The defect in platelet activation induced by trauma sera is distal to receptor activation since agonist-induced Ca2+ flux is elevated in the presence of trauma sera owing to complement deposition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27355402     DOI: 10.1097/SHK.0000000000000675

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  10 in total

Review 1.  Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2020-09-09       Impact factor: 2.490

2.  Proteomics of Coagulopathy Following Injury Reveals Limitations of Using Laboratory Assessment to Define Trauma-Induced Coagulopathy to Predict Massive Transfusion.

Authors:  Hunter B Moore; Matthew D Neal; Marnie Bertolet; Brian A Joughin; Michael B Yaffe; Christopher D Barrett; Molly A Bird; Russell P Tracy; Ernest E Moore; Jason L Sperry; Brian S Zuckerbraun; Myung S Park; Mitchell J Cohen; Stephen R Wisniewski; James H Morrissey
Journal:  Ann Surg Open       Date:  2022-05-25

3.  Exploratory Investigation of the Plasma Proteome Associated with the Endotheliopathy of Trauma.

Authors:  Joseph D Krocker; Kyung Hyun Lee; Hanne H Henriksen; Yao-Wei Willa Wang; Erwin M Schoof; Sigurdur T Karvelsson; Óttar Rolfsson; Pär I Johansson; Claudia Pedroza; Charles E Wade
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

4.  Ability of Fibrin Monomers to Predict Progressive Hemorrhagic Injury in Patients with Severe Traumatic Brain Injury.

Authors:  Pierre Esnault; Quentin Mathais; Erwan D'Aranda; Ambroise Montcriol; Mickaël Cardinale; Pierre-Julien Cungi; Philippe Goutorbe; Christophe Joubert; Arnaud Dagain; Eric Meaudre
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

5.  Single-Cell Transcriptomics Reveals Compartment-Specific Differences in Immune Responses and Contributions for Complement Factor 3 in Hemorrhagic Shock Plus Tissue Trauma.

Authors:  Guang Fu; Tianmeng Chen; Junru Wu; Ting Jiang; Da Tang; Jillian Bonaroti; Julia Conroy; Melanie J Scott; Meihong Deng; Timothy R Billiar
Journal:  Shock       Date:  2021-12-01       Impact factor: 3.454

Review 6.  HUS and atypical HUS.

Authors:  T Sakari Jokiranta
Journal:  Blood       Date:  2017-04-17       Impact factor: 25.476

7.  Complement component 5 promotes lethal thrombosis.

Authors:  Tomohiro Mizuno; Kengo Yoshioka; Masashi Mizuno; Mie Shimizu; Fumihiko Nagano; Tomoyuki Okuda; Naotake Tsuboi; Shoichi Maruyama; Tadashi Nagamatsu; Masaki Imai
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

Review 8.  Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review.

Authors:  Alexander Fletcher-Sandersjöö; Bo-Michael Bellander
Journal:  Thromb Res       Date:  2020-06-18       Impact factor: 3.944

Review 9.  Does Complement-Mediated Hemostatic Disturbance Occur in Traumatic Brain Injury? A Literature Review and Observational Study Protocol.

Authors:  Alexander Fletcher-Sandersjöö; Marc Maegele; Bo-Michael Bellander
Journal:  Int J Mol Sci       Date:  2020-02-26       Impact factor: 5.923

10.  Traumatic Brain Injury Is Associated With Both Hemorrhagic Stroke and Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Donghao Qu; Wenchen Li; Shuyan Zhang; Ri Li; Haifeng Wang; Bo Chen
Journal:  Front Neurosci       Date:  2022-02-10       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.